Overcoming gastrointestinal mucosal barriers: Mechanistic innovations and technical advances in mucosal targeting strategies for animal oral vaccines

IF 2.8 2区 农林科学 Q3 MICROBIOLOGY
Veterinary microbiology Pub Date : 2026-05-01 Epub Date: 2026-03-06 DOI:10.1016/j.vetmic.2026.110983
Meijun Yu , Yue Li , Zhaojun Wang , Ping Han , Yanping Jiang , Wen Cui , Yijing Li , Lijie Tang , Shuo Jia , Hongzhe Zhao , Yingying Ma , Jiaxuan Li , Xiaona Wang
{"title":"Overcoming gastrointestinal mucosal barriers: Mechanistic innovations and technical advances in mucosal targeting strategies for animal oral vaccines","authors":"Meijun Yu ,&nbsp;Yue Li ,&nbsp;Zhaojun Wang ,&nbsp;Ping Han ,&nbsp;Yanping Jiang ,&nbsp;Wen Cui ,&nbsp;Yijing Li ,&nbsp;Lijie Tang ,&nbsp;Shuo Jia ,&nbsp;Hongzhe Zhao ,&nbsp;Yingying Ma ,&nbsp;Jiaxuan Li ,&nbsp;Xiaona Wang","doi":"10.1016/j.vetmic.2026.110983","DOIUrl":null,"url":null,"abstract":"<div><div>Infectious diseases caused by pathogenic microorganisms (such as <em>Escherichia coli</em>, <em>Avian influenza virus</em> (AIV), <em>Rotavirus</em>, etc.) that primarily invade through mucosal surfaces like the digestive tract and respiratory tract not only severely restrict the development of the livestock and poultry breeding industry, resulting in huge economic losses, but also threaten public health security due to the risk of cross-species transmission. Oral vaccines, by simulating natural infection routes to activate the mucosal immune system, have advantages such as ease of administration, wide applicability, and avoidance of injection stress, thus becoming an important means to prevent and control mucosal infectious diseases. However, due to the acidic environment of the gastrointestinal tract, degradation by digestive enzymes, and obstruction by mucosal barriers, the stability and immunogenicity of antigens are significantly reduced, which greatly limits the application of oral vaccines. Mucosal targeting strategy is the core technology to break through the above bottlenecks. Through antigen protection and sustained release, precise targeting of immune cells, and carrier adjuvant effect, it can efficiently activate synergistic responses between mucosal immunity (such as secretory immunoglobulin A (SIgA) production) and systemic immunity. This article systematically reviews the technological advances in mucosal targeting strategies for oral vaccines, including the dynamic process of vaccines <em>in vivo</em>, the biological barriers to be overcome, and specific targeting techniques for immune cells such as M cells and dendritic cells. Meanwhile, drawing on cutting-edge applications of drug targeting technology and artificial intelligence in antigen design, it provides theoretical references and research ideas for the construction of safe and efficient mucosal-targeted oral vaccines for animals.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"316 ","pages":"Article 110983"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113526001148","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Infectious diseases caused by pathogenic microorganisms (such as Escherichia coli, Avian influenza virus (AIV), Rotavirus, etc.) that primarily invade through mucosal surfaces like the digestive tract and respiratory tract not only severely restrict the development of the livestock and poultry breeding industry, resulting in huge economic losses, but also threaten public health security due to the risk of cross-species transmission. Oral vaccines, by simulating natural infection routes to activate the mucosal immune system, have advantages such as ease of administration, wide applicability, and avoidance of injection stress, thus becoming an important means to prevent and control mucosal infectious diseases. However, due to the acidic environment of the gastrointestinal tract, degradation by digestive enzymes, and obstruction by mucosal barriers, the stability and immunogenicity of antigens are significantly reduced, which greatly limits the application of oral vaccines. Mucosal targeting strategy is the core technology to break through the above bottlenecks. Through antigen protection and sustained release, precise targeting of immune cells, and carrier adjuvant effect, it can efficiently activate synergistic responses between mucosal immunity (such as secretory immunoglobulin A (SIgA) production) and systemic immunity. This article systematically reviews the technological advances in mucosal targeting strategies for oral vaccines, including the dynamic process of vaccines in vivo, the biological barriers to be overcome, and specific targeting techniques for immune cells such as M cells and dendritic cells. Meanwhile, drawing on cutting-edge applications of drug targeting technology and artificial intelligence in antigen design, it provides theoretical references and research ideas for the construction of safe and efficient mucosal-targeted oral vaccines for animals.
克服胃肠粘膜屏障:动物口服疫苗粘膜靶向策略的机制创新和技术进步
病原微生物(如大肠杆菌、禽流感病毒(AIV)、轮状病毒等)主要通过消化道、呼吸道等粘膜表面侵入的传染病,不仅严重制约了畜禽养殖业的发展,造成巨大的经济损失,而且由于存在跨物种传播的风险,威胁着公共卫生安全。口服疫苗通过模拟自然感染途径激活粘膜免疫系统,具有给药方便、适用范围广、避免注射应激等优点,成为预防和控制粘膜感染性疾病的重要手段。然而,由于胃肠道的酸性环境、消化酶的降解和粘膜屏障的阻碍,抗原的稳定性和免疫原性明显降低,这极大地限制了口服疫苗的应用。粘膜靶向策略是突破上述瓶颈的核心技术。通过抗原保护和缓释、对免疫细胞的精准靶向、载体佐剂作用,有效激活粘膜免疫(如分泌性免疫球蛋白A (SIgA)的产生)与全身免疫之间的协同反应。本文系统综述了口服疫苗粘膜靶向策略的技术进展,包括疫苗在体内的动态过程、需要克服的生物屏障以及针对免疫细胞(如M细胞和树突状细胞)的特异性靶向技术。同时,借鉴药物靶向技术和人工智能在抗原设计中的前沿应用,为构建安全高效的动物黏膜靶向口服疫苗提供理论参考和研究思路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Veterinary microbiology
Veterinary microbiology 农林科学-兽医学
CiteScore
5.90
自引率
6.10%
发文量
221
审稿时长
52 days
期刊介绍: Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal. Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge. Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书